Michael McDonald advises on all types of mergers and acquisitions, as well as joint ventures and restructurings.

He has represented corporates, financial institutions, and private equity funds on a broad range of public and private M&A transactions in various sectors, often involving cross-border issues. He has particular experience on European acquisitions by North American corporates and private equity funds.

Michael joined the firm in 2006 as a partner. Prior to Cleary he was an English-qualified M&A partner at Allen & Overy in London.

Notable Experience

  • Agilent in its acquisition of Danish-based cancer diagnostics company Dako from EQT.

  • Amgen in its acquisition of Mustafa Nevzat Pharmaceuticals (MN), the Turkish biotech company.

  • Keysight Technologies in its takeover offer for Anite plc.

  • Stanley Black & Decker in its public takeover of Niscayah, and Truvo in its global restructuring.

  • UTC in its acquisition of Rentokil’s global security division.

  • 3M Company in its public takeover of Biotrace International plc.

  • 3M Company in its public takeover of E Wood Holdings plc.

  • QIA in relation to the acquisition by a consortium of National Grid’s gas distribution business in the UK.

  • Barclays on the sale of its global index business to Bloomberg.

  • TPG Capital in its acquisition of TSL Education Group Limited (TSL) from Charterhouse Capital Partners.

  • Dexia SA in the sale of its 50 percent stake in RBC Dexia Investor Services Limited to Royal Bank of Canada.

  • Highstar Capital on the sale of its 25 percent stake in London City Airport to a consortium.

  • JC Flowers in the sale of NIBC to Kaupthing as well as the acquisition of Fidea.

See More